Gerresheimer AG (GRRMF)
31.57
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.090B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -56.78% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 0.4399 |
| Price to Book Value | 0.6645 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0456 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.542 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 85.05% |
Profile
| Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices, Primary Packaging Glass, and Advanced Technologies. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The Advanced Technologies segment focuses on the technical and digital solutions to improve patient treatment outcomes. The company was founded in 1864 and is headquartered in Duesseldorf, Germany. |
| URL | http://www.gerresheimer.com |
| Investor Relations URL | N/A |
| HQ State/Province | Nordrhein-Westfalen |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Jun. 10, 2026 (est.) |
| Last Earnings Release | Mar. 31, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 09, 2025 |
Profile
| Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices, Primary Packaging Glass, and Advanced Technologies. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The Advanced Technologies segment focuses on the technical and digital solutions to improve patient treatment outcomes. The company was founded in 1864 and is headquartered in Duesseldorf, Germany. |
| URL | http://www.gerresheimer.com |
| Investor Relations URL | N/A |
| HQ State/Province | Nordrhein-Westfalen |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Jun. 10, 2026 (est.) |
| Last Earnings Release | Mar. 31, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 09, 2025 |